Calcific aortic valve stenosis and COVID-19: clinical management, valvular damage, and pathophysiological mechanisms
Abstract. Patients with corona virus disease (COVID)-19 are prone to a variety of myocardial and vascular complications. Recent studies suggest that cardiac valves are also potential targets for the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Calcific aortic valve stenosis (CAVS) i...
Main Authors: | Magnus Bäck, Mohammed Hashem, Anna Giani, Sven-Christian Pawelzik, Anders Franco-Cereceda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2022-03-01
|
Series: | Cardiology Plus |
Online Access: | http://journals.lww.com/10.1097/CP9.0000000000000001 |
Similar Items
-
TLR7 Expression Is Associated with M2 Macrophage Subset in Calcific Aortic Valve Stenosis
by: Glykeria Karadimou, et al.
Published: (2020-07-01) -
Proteoglycan 4 is Increased in Human Calcified Aortic Valves and Enhances Valvular Interstitial Cell Calcification
by: Gonzalo Artiach, et al.
Published: (2020-03-01) -
Telomere Length in Valve Tissue Is Shorter in Individuals With Aortic Stenosis and in Calcified Valve Areas
by: Ilona Saraieva, et al.
Published: (2021-03-01) -
Oxidative stress and valvular endothelial cells in aortic valve calcification
by: Li Shu, et al.
Published: (2023-07-01) -
Pulse Wave Morphology Changes in Aortic Valve Stenosis Detected with Cardio-Ankle Vascular Index
by: Plunde O, et al.
Published: (2023-05-01)